Trade Summary

2 days ago, JOHNSON JOHN, serving as Dir at Xeris Biopharma Holdings, Inc. (XERS), sold 15,000 shares at $6.09 per share, for a total transaction value of $91,422.00. Following this transaction, JOHNSON JOHN now holds 683,083 shares of XERS.

This sale represents a 2.15% decrease in JOHNSON JOHN's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 5, 2026 at 6:17 PM ET, 1 day after the trade was made.

Xeris Biopharma Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.